Publications by authors named "A Wilkowska"

Background: Electroconvulsive therapy (ECT) is a safe and effective treatment for several major psychiatric conditions, including treatment-resistant depression, mania, and schizophrenia; nevertheless, its use remains controversial. Despite its availability in some European countries, ECT is still rarely used in others. This study aims to investigate the experiences and attitudes of early career psychiatrists (ECPs) across Europe towards ECT and to examine how their exposure to ECT influences their perceptions.

View Article and Find Full Text PDF

The purpose of this research was to investigate the prebiotic effects of different fractions of pectin-derived oligosaccharides (POSs) from apple pomace (AP) in relation to their molecular weight (MW), structure, and composition. Enzymatic treatment of the apple pomace resulted in high-molecular-weight arabinans and rhamnogalacturonans (MW 30-100 kDa, MW 10-30 kDa), as well as oligomeric fractions with molecular weights of less than 10 kDa, consisting mainly of homogalacturonan. The biological potential of the POSs against various lactobacilli and bifidobacteria was evaluated.

View Article and Find Full Text PDF

The European Clozapine Task Force is a group of psychiatrists and pharmacologists practicing in 18 countries under European Medicines Agency (EMA) regulation, who are deeply concerned about the underuse of clozapine in European countries. Although clozapine is the most effective antipsychotic for people with treatment-resistant schizophrenia, a large proportion of them do not have access to this treatment. Concerns about clozapine-induced agranulocytosis and stringent blood monitoring rules are major barriers to clozapine prescribing and use.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aims to address the ongoing symptoms of depression, particularly focusing on residual hypersomnia, which significantly impacts daily life and is under-researched.
  • - A systematic review analyzed data from multiple databases to assess the prevalence and treatment options for residual hypersomnia in depression, finding that current treatments, including modafinil and CPAP for patients with sleep apnea, show limited long-term effectiveness.
  • - The research highlights challenges like unclear definitions and a lack of rigorous trials, emphasizing the need for more studies to improve the understanding and management of residual hypersomnia in depressed patients.
View Article and Find Full Text PDF